Search
Menu
Home
HTB
2013
December
December 2013
Contents
Editorial
Volume 14 Number 11/12 November/December 2013
Supplements
Guide to HIV and HCV coinfection (November 2013)
Conference reports
44th Union World Conference on Lung Health, 30 October – 3 November 2013, Paris
Preventing and treating TB in children – more baby steps
14th European AIDS Conference (EACS), 16-19 October 2013, Brussels
Dolutegravir superior to darunavir/r at week 48 in open label treatment naïve study
GSK744: 24-week results with oral integrase inhibitor planned for once-monthly injections
Cenicriviroc: 48 week results compared to efavirenz
Approaches to once-daily raltegravir: new formulation likely to require food
DSMB stops boosted atazanavir monotherapy study due to virological failure
Recreational drug use is common in HIV positive gay men and is extensive in a significant minority
Caution against prolonged use of bisphosphonates in patients with mild-moderate fracture risk
Osteoporosis triples risk of later fracture in 1000-person US HIV group
Bone turnover marker changes early in ART predict bone loss after 96 week
Low HDL cholesterol is main lipid abnormality in HIV+/HIV- comparison
Classic risk factors, but not HIV, linked to arterial stiffness in middle-aged
Antiretrovirals
Elvitegravir approved in EU: data on food and drug interactions
ViiV file 572-trii fixed dose combination in the US: positive opinion to approve dolutegravir in the EU
Treatment access
Obama increases US contribution to Global Fund to $5 billion over three years
HIV struggle in South Africa undermined by medicine stockouts and mismanagement
Paediatric care
Paediatric guidelines on the prevention and treatment of OIs (November 2013)
Guidelines
European guidelines launched at EACS (2013)
US HIV guidelines update information on integrase inhibitors (Oct 2013)
Side effects
Efavirenz is associated with higher suicide risk in meta-analysis of four ACTG studies
Hepatitis coinfection
EU recommends approval of sofosbuvir for HCV
Compassionate use of declatasvir with sofosbuvir for people in urgent need of HCV treatment
HIV prevention and transmission
The little blue pill that can stop HIV: PROUD study enrolling gay men in the UK
Basic science and immunology
Dual HIV infection in long term nonprogressor elite controllers
On the web
Online journals
PDFs
Volume 14 Number 11/12 November/December 2013 PDF
HTB RSS
Early access
TAG challenges HIV vaccine cuts as Robert F. Kennedy fires entire CDC vaccine expert advisory panel
6 June 2025
Gates Foundation commits to providing lenacapavir as PrEP next year
3 June 2025
All early access reports
Current issues
June 2025
May 2025
April 2025
Back issues
Special report
Latest news on the US crisis and its impact on global health
1 June 2025
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate